RCT Comparing Methadone and Buprenorphine in Pregnant Women

Completed · Phase 3

Conditions studied: Opioid Related Disorders, Pregnancy, Opioid Dependence

In brief

Children born to women who abuse drugs have a high risk of being born with birth defects and developmental problems. Methadone is a drug that is commonly used for treating opioid dependence. However, its use by a pregnant woman can cause severe withdrawal symptoms in a newborn because of the prenatal exposure. The purpose of this study is to evaluate the effectiveness of buprenorphine, another drug, versus methadone in reducing withdrawal symptoms in children born to opioid-dependent women.

Key facts

Study ID
NCT00271219
Run by
Johns Hopkins University
People needed
175
Starts
2005-07-01
Expected to finish
2010-06-01
Last updated by the study team
2015-08-05

Who can join

Age: 18 and older, up to 41. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.